SanBio Company Statistics

Total Valuation

SanBio Company has a market cap or net worth of JPY 146.70 billion. The enterprise value is 132.86 billion.

Market Cap	146.70B
Enterprise Value	132.86B

Important Dates

The next estimated earnings date is Friday, June 12, 2026.

Earnings Date	Jun 12, 2026
Ex-Dividend Date	n/a

Share Statistics

SanBio Company has 78.03 million shares outstanding. The number of shares has increased by 6.17% in one year.

Current Share Class	78.03M
Shares Outstanding	78.03M
Shares Change (YoY)	+6.17%
Shares Change (QoQ)	+6.58%
Owned by Insiders (%)	24.87%
Owned by Institutions (%)	-1.45%
Float	58.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	10.78
P/TBV Ratio	10.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-34.58
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.04

Financial Position

The company has a current ratio of 29.01, with a Debt / Equity ratio of 0.09.

Current Ratio	29.01
Quick Ratio	28.25
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.33
Interest Coverage	-105.39

Financial Efficiency

Return on equity (ROE) is -50.00% and return on invested capital (ROIC) is -27.89%.

Return on Equity (ROE)	-50.00%
Return on Assets (ROA)	-24.87%
Return on Invested Capital (ROIC)	-27.89%
Return on Capital Employed (ROCE)	-25.15%
Weighted Average Cost of Capital (WACC)	4.40%
Revenue Per Employee	n/a
Profits Per Employee	-132.48M
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-449.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.85% in the last 52 weeks. The beta is 0.03, so SanBio Company's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+12.85%
50-Day Moving Average	2,007.00
200-Day Moving Average	2,347.44
Relative Strength Index (RSI)	44.66
Average Volume (20 Days)	1,113,765

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.79B
Pretax Income	-4.29B
Net Income	-3.84B
EBITDA	-3.79B
EBIT	-3.79B
Earnings Per Share (EPS)	-52.55

Full Income Statement

Balance Sheet

The company has 15.08 billion in cash and 1.24 billion in debt, with a net cash position of 13.85 billion or 177.43 per share.

Cash & Cash Equivalents	15.08B
Total Debt	1.24B
Net Cash	13.85B
Net Cash Per Share	177.43
Equity (Book Value)	13.61B
Book Value Per Share	177.23
Working Capital	14.96B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.76 billion and capital expenditures -32.00 million, giving a free cash flow of -3.79 billion.

Operating Cash Flow	-3.76B
Capital Expenditures	-32.00M
Depreciation & Amortization	8.00M
Net Borrowing	812.00M
Free Cash Flow	-3.79B
FCF Per Share	-48.59

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SanBio Company does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.17%
Shareholder Yield	-6.17%
Earnings Yield	-2.62%
FCF Yield	-2.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2